Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Matías-Guiu

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Neurologia (Barcelona, Spain)|October 3, 2009
[Improvement and decision-making process of an article]Jorge Matías-Guiu, R García Ramos
Journal of Alzheimer'S Disease : JAD|October 19, 2020
Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal DementiaJordi A Matias-Guiu, Vanesa Pytel, Jorge Matías-Guiu
Multiple Sclerosis and Related Disorders|June 17, 2021
Underpinnings of verbal fluency in Multiple SclerosisAlfonso Delgado-Álvarez, Cristina Delgado-Alonso, Jorge Matías-Guiu, et al.
BMC Neurology|September 7, 2017
Amyotrophic lateral sclerosis modifies progenitor neural proliferation in adult classic neurogenic brain nichesLucía Galán, Ulises Gómez-Pinedo, Antonio Guerrero, et al.
Brain Research|October 11, 2011
CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: protection by resveratrol but not riluzoleMatilde Yáñez, Lucía Galán, Jorge Matías-Guiu, et al.
Multiple Sclerosis and Related Disorders|June 20, 2020
Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumabJorge Matías-Guiu, Paloma Montero-Escribano, Vanesa Pytel, et al.
Cephalalgia : an International Journal of Headache|September 8, 2010
One-year prevalence of migraine in Spain: a nationwide population-based surveyJorge Matías-Guiu, Jesus Porta-Etessam, Valentín Mateos, et al.
Acta Neurologica Scandinavica|March 26, 2019
What is the meaning of PASAT rejection in multiple sclerosis?Ana Cortés-Martínez, Jordi A Matias-Guiu, Vanesa Pytel, et al.
Neuroscience Letters|September 14, 2016
ITH33/IQM9.21 provides neuroprotection in a novel ALS model based on TDP-43 and Na<sup>+</sup>/Ca<sup>2+</sup> overload induced by VTDLamia Mouhid Al-Achbili, Ana J Moreno-Ortega, Jorge Matías-Guiu, et al.
Dementia and Geriatric Cognitive Disorders|April 7, 2017
Comparative Diagnostic Accuracy of the ACE-III, MIS, MMSE, MoCA, and RUDAS for Screening of Alzheimer DiseaseJordi A Matías-Guiu, María Valles-Salgado, Teresa Rognoni, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Neurologia (Barcelona, Spain)|October 3, 2009
[Improvement and decision-making process of an article]Jorge Matías-Guiu, R García Ramos
Journal of Alzheimer'S Disease : JAD|October 19, 2020
Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal DementiaJordi A Matias-Guiu, Vanesa Pytel, Jorge Matías-Guiu
Multiple Sclerosis and Related Disorders|June 17, 2021
Underpinnings of verbal fluency in Multiple SclerosisAlfonso Delgado-Álvarez, Cristina Delgado-Alonso, Jorge Matías-Guiu, et al.
BMC Neurology|September 7, 2017
Amyotrophic lateral sclerosis modifies progenitor neural proliferation in adult classic neurogenic brain nichesLucía Galán, Ulises Gómez-Pinedo, Antonio Guerrero, et al.
Brain Research|October 11, 2011
CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: protection by resveratrol but not riluzoleMatilde Yáñez, Lucía Galán, Jorge Matías-Guiu, et al.
Multiple Sclerosis and Related Disorders|June 20, 2020
Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumabJorge Matías-Guiu, Paloma Montero-Escribano, Vanesa Pytel, et al.
Cephalalgia : an International Journal of Headache|September 8, 2010
One-year prevalence of migraine in Spain: a nationwide population-based surveyJorge Matías-Guiu, Jesus Porta-Etessam, Valentín Mateos, et al.
Acta Neurologica Scandinavica|March 26, 2019
What is the meaning of PASAT rejection in multiple sclerosis?Ana Cortés-Martínez, Jordi A Matias-Guiu, Vanesa Pytel, et al.
Neuroscience Letters|September 14, 2016
ITH33/IQM9.21 provides neuroprotection in a novel ALS model based on TDP-43 and Na<sup>+</sup>/Ca<sup>2+</sup> overload induced by VTDLamia Mouhid Al-Achbili, Ana J Moreno-Ortega, Jorge Matías-Guiu, et al.
Dementia and Geriatric Cognitive Disorders|April 7, 2017
Comparative Diagnostic Accuracy of the ACE-III, MIS, MMSE, MoCA, and RUDAS for Screening of Alzheimer DiseaseJordi A Matías-Guiu, María Valles-Salgado, Teresa Rognoni, et al.
Pageof 11